Yunnan Baiyao Group Co.,Ltd 000538.SZ

Name: 000538.SZ quality scores
Creator: Stocktoria
License: https://stocktoria.com/terms/

CN · XSHE · XSHE · stock · Healthcare · website

Yunnan Baiyao Group Co.,Ltd (000538.SZ) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 4.71% (safety: stretched). FY2025 revenue was CN¥41.2B at a 12.5% net margin.

Chart by TradingView

6/9

Piotroski F — financial health

7.25

Altman Z″ — distress risk · safe

78.2%

Dividend payout · stretched

CN¥47.97 as of 2026-07-01 · -14.5% 1y

CN¥47.37CN¥57.5852-wk

Market cap USD$12.6B

P / E16.6×

Dividend yield4.71%

Net margin12.5%

Return on equity12.9%

Beta0.17

Employees9,286

Analyst price target

CN¥69.14 +44.1% vs last

· 10 analysts

range CN¥62.00 – CN¥82.20

Wall Street analyst consensus — a sentiment gauge, not our scoring.

About Yunnan Baiyao Group Co.,Ltd

Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmaceutical supply chain service solutions. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

Revenue trend · last 4y · up

How it ranks in Healthcare · percentile among 73 companies

Piotroski Fstronger than 36%

Net marginstronger than 52%

Return on equitystronger than 61%

Revenue growthstronger than 27%

Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 6/9 tests passed

Positive return on assets
Positive operating cash flow
Rising ROA
Cash flow exceeds net income
Lower long-term debt
Rising current ratio
No share dilution
Rising gross margin
Rising asset turnover

Altman Z″ components · safe zone

Component	Value
Working capital / assets	0.39
Retained earnings / assets	0.335
EBIT / assets	0.093
Equity / liabilities	2.836

FAQ

Is 000538.SZ financially healthy?

Yunnan Baiyao Group Co.,Ltd's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does 000538.SZ pay a dividend, and is it safe?

Yes. Yunnan Baiyao Group Co.,Ltd pays a dividend yielding about 4.71% with a 78.2% payout ratio, rated “stretched” for safety.

How profitable is 000538.SZ?

In FY2025, Yunnan Baiyao Group Co.,Ltd had a net margin of 12.5% and a return on equity of 12.9%.

Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.